aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · IEX Real-Time Price · USD
1.640
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.720
+0.080 (4.88%)
Pre-market: Jul 22, 2024, 9:14 AM EDT
aTyr Pharma Employees
As of December 31, 2023, aTyr Pharma had 59 total employees, including 56 full-time and 3 part-time employees. The number of employees decreased by 11 or -15.71% compared to the previous year.
Employees
59
Change (1Y)
-11
Growth (1Y)
-15.71%
Revenue / Employee
$9,966
Profits / Employee
-$914,051
Market Cap
113.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Augmedix | 1,430 |
American Well | 1,104 |
FONAR | 561 |
Karyopharm Therapeutics | 325 |
TELA Bio | 227 |
I-Mab | 220 |
Adagene | 174 |
RAPT Therapeutics | 131 |
ATYR News
- 7 weeks ago - aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR” - GlobeNewsWire
- 2 months ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - aTyr Pharma to Present Poster Describing Efzofitimod's Mechanism of Action at the American Thoracic Society 2024 International Conference - GlobeNewsWire
- 2 months ago - aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis - GlobeNewsWire
- 2 months ago - aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - aTyr Pharma to Participate in April Investor Conferences - GlobeNewsWire
- 4 months ago - aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results - GlobeNewsWire